European Multicentre Registry of Percutaneous Paravalvular Leak Closure

Launched by CENTRE CHIRURGICAL MARIE LANNELONGUE · Aug 16, 2022

Keywords

ClinConnect Summary

This clinical trial, called the European Multicentre Registry of Percutaneous Paravalvular Leak Closure, is studying a new procedure to treat leaks that can occur around heart valves after surgery. These leaks can lead to serious problems, including heart failure. The trial aims to understand how effective this procedure is for patients, especially in terms of improving their quality of life by possibly reducing symptoms like shortness of breath and the need for blood transfusions.

To participate in this trial, individuals need to be at least 16 years old and have been referred for the leak closure procedure. The trial is currently recruiting participants of all genders and ages ranging from 16 to 99. If someone joins the study, they can expect to be monitored closely to see how well the procedure works and whether it helps improve their daily life. The research is important because it will provide more information about this treatment option and how it affects patients’ overall well-being.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ≥16 years of age No opposition from the patient or the representative of the parental authority if the patient is a minor Patient referred for a percutaneous paraprosthetic leak closure procedure
• Exclusion Criteria:
• • \< 16 years old Refusal of the patient to participate in the observatory or of the legal representative if the patient is a minor